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Abstract
In the vertebrate embryo, the kidney is derived from the intermediate mesoderm. The LIM-class homeobox transcription
factor lhx1 is expressed early in the intermediate mesoderm and is one of the first genes to be expressed in the nephric
mesenchyme. In this study, we investigated the role of Lhx1 in specification of the kidney field by either overexpressing or
depleting lhx1 in Xenopus embryos or depleting lhx1 in an explant culture system. By overexpressing a constitutively-active
form of Lhx1, we established its capacity to expand the kidney field during the specification stage of kidney organogenesis.
In addition, the ability of Lhx1 to expand the kidney field diminishes as kidney organogenesis transitions to the
morphogenesis stage. In a complimentary set of experiments, we determined that embryos depleted of lhx1, show an
almost complete loss of the kidney field. Using an explant culture system to induce kidney tissue, we confirmed that
expression of genes from both proximal and distal kidney structures is affected by the absence of lhx1. Taken together our
results demonstrate an essential role for Lhx1 in driving specification of the entire kidney field from the intermediate
mesoderm.
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Introduction
The vertebrate kidney performs an essential function of
removing waste products from the blood and osmoregulation.
Although functionally similar, three types of kidneys have evolved
in vertebrates, the pronephros, mesonephros and metanephros,
with specification of each kidney induced by the preceding nephric
tissue. This inductive event results in a progressively more complex
organization ending with the metanephric kidney, which exists in
mammals and birds [1,2,3]. All three kidneys share the same basic
structure and organization of the functional unit, the nephron, but
differ mostly in the number and spatial assembly of nephrons.
Each nephron consists of the renal corpuscle and the renal tubule
[4]. In amphibians the pronephric kidney is the functional
embryonic kidney. In Xenopus laevis, it consists of a bilaterally
paired organ, comprising a single non-integrated nephron on each
side of the embryo [5].
The entire kidney field is derived from the intermediate
mesoderm, which lies between the paraxial and lateral plate
mesoderm. Within the intermediate mesoderm, specification of
renal progenitor cells follows a precise temporal and spatial
sequence of signaling events [6,7]. Tissues juxtaposed to the
intermediate mesoderm have been shown to influence patterning
of the kidney field. Embryological experiments in chicken revealed
that initial patterning of the kidney field is dependent upon signals
from the axial/paraxial mesoderm [2,3,8,9], with retinoic acid
(RA) emanating from the paraxial mesoderm required for the
initial specification of renal progenitor cells [7,10,11]. Recent
studies have demonstrated that ectopic expression of RA increases
the size of the kidney field, while blocking the pathway inhibits
specification [10,12]. In Xenopus, embryos treated with RA show
increased expression of early kidney markers and treatment of
Xenopus pluripotent explants with a combination of RA and Activin
induces most kidney cell types [10,13]. In addition, bone
morphogenetic proteins (BMP) originating from the lateral plate
mesoderm also influence kidney specification. Intermediate
mesoderm fate commitment is regulated by a dose-dependent
activation of the BMP signaling cascade along the embryonic
dorso-ventral axis [2,14]. Low levels of BMP activate intermediate
mesoderm gene expression, whereas high levels of BMP repress
intermediate mesoderm gene expression and activates lateral plate
mesoderm genes [14].
During embryogenesis, processes such as body axis determina-
tion, as well as tissue and regional specification, require the
participation of the LIM homeodomain family of transcription
factors [15]. The LIM homeodomain transcription factors contain
two cysteine-histidine rich motifs (LIM domains), a central
homeodomain and a C-terminal transactivation domain [16].
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The LIM domains are thought to function as protein interaction
modules that can regulate the function of different components in
a transcriptional complex [15]. The LIM homeodomain tran-
scription factor Lhx1 (formerly known as Xlim1 in Xenopus laevis),
interacts with the LIM binding protein, Ldb, and this interaction
triggers Lhx1 activation [17,18]. Lhx1 is initially expressed in the
Spemann-Mangold organizer in Xenopus [19], a region that
coordinates cell fate specification and axis formation [20,21]. In
mouse and Xenopus embryos, lhx1 is required for proper cell
movements during gastrulation [22]. In addition, hyperactive
forms of Lhx1 have been shown to induce axis duplication in
Xenopus embryos [23]. Taken together, these findings indicate a
conserved role of Lhx1 in early embryonic patterning.
Lhx1 is one of the earliest genes to be expressed in the
pronephric anlagen [24,25,26,27,28]. In Xenopus, expression of
lhx1 in the lateral plate mesoderm and intermediate mesoderm is
initially seen by stage 12.5, starts to condense into a stripe of
intermediate mesoderm between stages 15–18, converges to the
nephric field at around stage 19, and finally is expressed in the
presumptive nephrostomes and tubule at stage 29/30 [25,29].
When a dominant-negative form of lhx1 is expressed in the
anterior kidney field, expression of proximal tubule markers is lost
[30]. Coexpression of lhx1 and pax8 results in the development of
enlarged kidney and the formation of ectopic pronephric tubules
[25]. In addition, lhx1 expression has been shown to be an early
molecular marker of the forming zebrafish mesonephros and the
first molecular marker of renal progenitor cells during adult
zebrafish nephrogenesis [31]. Lhx1 also plays an important role at
multiple stages of mammalian kidney development. In the mouse,
lhx1 is expressed early in the intermediate mesoderm [24,32] and
is required for the correct patterning of the kidney field [33]. Later
in the developing metanephros, Lhx1 is required for ureteric bud
morphogenesis and patterning of the nephric vesicle [34,35].
Finally, in Xenopus embryos, downregulation of lhx1 is required for
proper differentiation of the pronephric kidney. Persistent lhx1
expression in miR-30a-5p depleted embryos results in normal
kidney field specification, but in a failure of kidney cells to
terminally differentiate [36].
In the present report, we address the involvement of Lhx1 in
events that control specification of renal progenitor cells from the
intermediate mesoderm. We approach this question by studying
the development of the presumptive pronephros in embryos in
which lhx1 is either overexpressed or depleted and show that
pronephric kidney formation is drastically affected. In addition, by
overexpressing a constitutively-active form of Lhx1 in a tempo-
rally-controlled manner, we establish that this transcription factor
can expand the nephric field during the kidney specification stage
[37,38]. Finally, by using an in vitro explant culture system and
microarray analysis we demonstrate that loss of lhx1 results in lack
of expression of markers from all the domains of the kidney. Taken
together, the data suggest that lhx1 expression is necessary for the
early patterning the of entire kidney field.
Results
Over-expression of a constitutively-active form of Lhx1
expands the kidney field
Lhx1 and pax8 are expressed early in the pronephric anlagen
(Fig. S1) and coexpression of these two genes has a synergistic
effect that results in the development of an enlarged kidney and/or
the formation of ectopic pronephric tubules [25,39]. For a more
detailed study of lhx1 over-expression in Xenopus pronephric kidney
formation without pax8 coexpression [25], we used two constitu-
tively-active forms of Lhx1 [23]. In Xenopus, lhx1 is highly
expressed in the organizer region of the early gastrula embryo,
and perturbation of endogenous expression in this region causes
gastrulation defects [19,22,23]. To lessen the effect of these
gastrulation defects, we targeted the ventral region of the embryo.
Specifically, we injected one of the V2 blastomeres (1xV2) of 8-cell
embryos since a preponderance of the kidney tissue has been
shown by fate mapping to be derived from the V2 blastomeres
[40].
We tested the constitutively-active constructs for their ability to
induce expansion of the pronephric anlage as assessed by pax8 in
situ hybridization at stage 20 (Fig. S2, S3). The constructs are
fusions of Lim domain binding protein 1 (Ldb1) and Lhx1, which
had been shown to functionally replace Lhx1 in depletion and
over-expression assays [23]. The Ldb1-Lhx1 constitutively-active
construct (LL-CA) is a fusion of the Ldb1 dimerization domain
with the linker, C-terminal and homeodomain of Lhx1, while the
Ldb1-Lhx1-VP16 construct (LL-VP16) replaces the Lhx1 C-
terminal domain with the transactivation domain of the viral
protein VP16 [23]. Injection of 1200 pg of LL-CA mRNA (1xV2)
induced expansion of the pronephric kidney in 82% of the injected
embryos (Fig. S2N), while 200 pg of LL-VP16 mRNA induced
expansion of the pronephric kidney in 70% of the injected
embryos (Fig. 1A–1C, 1N). Based on these results, we decided to
continue with the LL-VP16 construct since it allowed us to inject a
lower dose of mRNA to achieve a similar effect. We limited the
dose of LL-VP16 mRNA to 200 pg, since at higher doses injected
embryos showed a misshapen kidney field (Fig. S3L).
To address how the expansion of the pronephric anlagen
translates to the differentiated kidney field, we performed whole-
mount immunostaining with two antibodies, 3G8 and 4A6, that
recognize the proximal tubules or the early distal and distal
tubules, respectively [41,42]. Embryos injected with LL-VP16
mRNA and stained with 3G8 antibody showed a larger
differentiated tubule epithelium (81%) (Fig. 1D–1F). Staining
with 4A6 showed expanded early distal and distal tubules on the
injected side of embryos (80%) (Fig. 1G–1I). Double immuno-
staining showed that both regions of the pronephros are enlarged
on the side of the embryos injected with LL-VP16 mRNA, but the
relative juxtaposition of each marker is not affected (Fig. 1J–1M).
These results demonstrate that over-expression of constitutively-
active Lhx1 induces an expansion of the kidney field, without
overtly changing the patterning of the tubule segments.
Lhx1-mediated expansion of the kidney field takes place
during a restricted temporal window
In order to establish a more precise time frame in which Ldb1-
Lhx1 functions during pronephric kidney development, we
temporally-controlled LL-VP16 activation by fusing the gluco-
corticoid receptor (GR) ligand-binding domain to the 39 end of
the LL-VP16 construct (LL-VP16-GR). Addition of dexametha-
sone (Dex) results in nuclear translocation of the fusion protein
and activation of LL-VP16-GR. Embryos were injected with
200 pg of LL-VP16-GR mRNA (1xV2) and Dex was added at
different stages prior to or during pronephric kidney specification
(stages 10, 12.5, 15, 18) and morphogenesis (stages 21 and 24)
[37]. Injected and uninjected control embryos were fixed at stage
31 and processed for in situ hybridization of pax8. When Dex was
added to injected embryos at stages 10 and 12.5, 53% and 56%
of the embryos, respectively, showed an expansion of pax8
expression (Fig. 2A–2D, 2M). When Dex was added later during
specification (stages 15 and 18) a greater percentage of the
embryos (84% and 79%, respectively) showed an expanded
kidney field (Fig. 2E–2H, 2M). Only 40% and 24% of the
embryos treated with Dex at stages 21 and 24, respectively,
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showed expansion (Fig. 2I–2L, 2M). To confirm possible axis
duplication was not contributing to the expanded kidney field the
embryos were immunostained for either the notochord marker
MZ15, or the muscle-specific antibody 12/101 [25,43]. Neither
the MZ15 or 12/101 staining showed duplicate axes (Fig. 2A–L,
Fig. S4). The efficacy of LL-VP16-GR to induce expansion of
the pronephric kidney field was significantly reduced when
kidney organogenesis transitions from the specification to
morphogenesis stages [37]. Taken together, these data indicate
that Ldb1-Lhx1 transcriptional complex plays an important role in
regulating the size of the kidney field during the specification
stage, but this effect is reduced once the kidney field undergoes
morphogenesis.
Lhx1 over-expression expands intermediate mesoderm
progenitors at the expense of paraxial mesoderm
To assess whether expansion of the pronephric kidney in
embryos overexpressing LL-VP16 was due to increased
proliferation of intermediate mesoderm progenitors or a fate
transformation event, we treated LL-VP16 mRNA injected
embryos (1xV2) at stage 10.5/11 with the DNA synthesis
inhibitors hydroxyurea and aphidicolin (HUA), which have
been shown to block cell division without affecting cell fate
determination [44]. Embryos were fixed at stage 20 and assayed
for changes in pax8 expression. As compared to LL-VP16
mRNA injected embryos, embryos injected with LL-VP16
mRNA and treated with HUA showed a dramatic decrease in
the number of mitotic cells, assessed by immunofluorescence
with anti-phospho-Histone H3 antibody, but still displayed an
expansion of the pronephric kidney field (91% compare to 82%)
(Fig. 3A–3H). This suggests that an increase in cell proliferation
is unlikely to be a major contributor to Ldb1-Lhx1 mediated
expansion of the kidney field.
Coexpression of lhx1 and pax8 induces enlarged pronephroi
and an associated reduction of somitic tissue [25]. Therefore, we
wanted to determine if Lhx1 affects tissue juxtaposed to the
intermediate mesoderm by using LL-VP16 over-expression. To
investigate the possibility that cells from the paraxial mesoderm
and/or lateral plate mesoderm have acquired intermediate
mesoderm fate, we analyzed expression of the paraxial mesoderm
marker myoD and the lateral plate mesoderm marker scl by in situ
hybridization. We observed reduced myoD expression on the
injected side of embryos at stage 20 (63%) (Fig. 3I, 3J) and at
stage 26 (87%) (Fig. 3K, 3L). Expression of scl was not affected
in embryos at either stage 20 (Fig. 3M, 3N) or stage 26 (Fig. 3O,
3P) injected with LL-VP16 RNA. These results suggest that
Ldb1-Lhx1 transcriptional complex is able to induce fate
transformation of cells from the paraxial mesoderm to contribute
to the intermediate mesoderm and adopt a pronephric kidney
fate.
Depletion of lhx1 using lhx1-AS results in a loss of the
kidney field
Our lhx1 over-expression results indicate this transcription
factor has an important role in early specification of the renal
progenitor cells. To further investigate the role of Lhx1 in
pronephric kidney development, we injected embryos with lhx1
N,N-diethylethylenediamine antisense oligonucleotide (lhx1-AS)
[45]. Embryos were injected at the 8-cell stage (1xV2) with either
lhx1-AS or a control N,N-diethylethylenediamine antisense oligo-
nucleotide (ctrl-AS) [22]. We looked at the expression of the early
pronephric marker pax8 as an indication of kidney formation and
observed a dose-dependent reduction of pax8 expression on the
injected side of stage 20 embryos (Fig. S5). As compared to
uninjected embryos, 300 pg of ctrl-AS showed no effect on pax8
expression (Fig. 4A, 4B). Injection of 300 pg of lhx1-AS caused
either reduced or absent pax8 expression in 100% of the embryos
(Fig. 4C, 4M). Rescue experiments using zebrafish lhx1 synthetic
mRNA, insensitive to lhx1-AS, showed a marked rescue of the
kidney field, which verified that the lhx1-AS phenotype is specific
for depletion of Xenopus lhx1 mRNA (Fig. 4M). The absence of the
pronephric mesenchyme in lhx1-AS embryos indicates that
expression of lhx1 is essential for the early intermediate mesoderm
patterning.
We analyzed expression of definitive kidney markers of the
pronephric tubule using the antibodies 3G8 and 4A6. Injection of
the ctrl-AS showed no differences with the uninjected embryos
(Fig. 4D, 4E, 4G, 4H). The absence of 3G8 and 4A6 staining on
the side of the embryos injected with 300 pg of lhx1-AS indicated a
loss of differentiated cell types in the proximal and early distal
regions of the pronephric kidney (76% and 91%, respectively)
(Fig. 4F, 4I). We also confirmed the absence of the pronephric
tubule by performing in situ hybridization for b1-NaK-ATPase
expression. Pronephric transcripts of the b1 subunit appear at
stage 26 and mark the onset of the maturation phase during
pronephric kidney organogenesis [46]. As expected, we observed
reduced b1-NaK-ATPase expression (72% of embryos) when lhx1
expression was depleted (Fig. 4L). The lack of expression of these
markers indicates an absence of differentiated pronephric kidney
suggesting an essential role for Lhx1 in specification of the kidney
field.
In vitro explant culture and microarray analysis
demonstrates lhx1 expression is required for specification
of the entire kidney field
The lhx1-AS depletion studies support the idea that lhx1 is
involved in driving specification of intermediate mesoderm into
nephrogenic mesenchyme. Lhx1 is initially expressed throughout
the entire intermediate mesoderm (Fig. S1). Therefore, we wished
to determine if the entire kidney field or specific sub-domains are
affected by the absence of lhx1. Instead of using lhx1-AS targeted
Figure 1. Over-expression of lhx1 induces expansion of the pronephric kidney. Embryos were injected (1xV2) with 200 pg of LL-VP16
mRNA at the 8-cell stage. (A–C) In situ hybridization of embryos at stage 20 for the early pronephric marker pax8. (A) Uninjected embryo. (B–C)
Control and injected sides of the same embryo are shown. (C) Expansion of pax8 expression was observed in 83% of the embryos (n = 33). Kidney
fields are highlighted with black brackets. (D–I) 3G8 and 4A6 whole-mount immunostaining were carried out at stages 32 and 37/38, respectively.
(D, G) Uninjected embryos. (E, F, H, I) Control and injected sides of the same embryo. (F, I) Larger tubule epithelium with 3G8 was observed in 81%
of the embryos (n = 32) and expanded intermediate and distal tubules with 4A6 were observed in 80% of the embryos (n = 30). (D–F) Insets show
enlargements of 3G8 staining of the proximal tubule. (J–M) 3G8, 4A6 double whole-mount immunostaining of stage 42 embryos. (K) Magnification of
the pronephric kidney of uninjected embryo. (M) Magnification of the pronephric kidney of injected embryo. (N) Bar graph showing the percentage
of embryos injected at the different doses of LL-VP16 that showed expansion of pax8 expression. LL-VP16 mRNA 50 pg: expansion of pax8 expression
was observed in 35% of the embryos (n = 26). LL-VP16 mRNA 100 pg: expansion of pax8 expression was observed in 53% of the embryos (n = 30). LL-
VP16 mRNA 200 pg: expansion of pax8 expression was observed in 70% of the embryos (n = 30). LL-VP16 mRNA 300 pg: expansion of pax8
expression was observed in 93% of the embryos (n = 27).
doi:10.1371/journal.pone.0018858.g001
Lhx1 Drives Kidney Field Specification
PLoS ONE | www.plosone.org 4 April 2011 | Volume 6 | Issue 4 | e18858
injections to study expression of kidney markers in whole embryos,
one marker at a time, we performed a microarray analysis using an
explant culture system. Xenopus tissue explants can be surgically
isolated and cultured under specific conditions to be driven
towards many distinct tissue types [47,48]. Pronephric cell fates is
induced by culturing isolated explants in the presence of Activin
and RA (AcRA) [49,50,51]. Treatment of dissected explants from
stage 8–9 embryos with 10 ng/ml Activin and 161024 M RA can
induce differentiation of the pluripotent ectoderm into pan-kidney
tissue in approximately 90% of the treated explants [49]. For the
lhx1-depletion experiments, both blastomeres of 2-cell embryos
were injected with a total of 800 pg lhx1-AS. Explants were
dissected and treated with AcRA and expression of pax8 at stage
15 (based on timing of paired control whole embryos) was
analyzed. We observed a lack of induction of pax8 expression in
lhx1-depleted explants under AcRA treatment conditions in which
expression of this gene is normally induced (Fig. S6A). Based on
this observation, microarray analysis was carried out to identify
genes whose expression is affected by the absence of lhx1.
Explants of embryos injected with 800 pg of lhx1-AS were
dissected, treated with pronephric tissue inductive conditions
(AcRA), and harvested between stages 13.5 and 14 (Fig. S6B).
Explants from uninjected embryos treated with AcRA and
untreated, as well as explants from lhx1-AS injected embryos
untreated were also harvested. The microarray data was subjected
to statistical analysis and pair-wise comparison of each sample was
included. In order to produce a manageable data set of affected
genes, the cutoff point for significant regulatory changes was set at
a minimum of a 4-fold increase in gene expression of AcRA
treated caps versus untreated control and 2-fold decrease or
greater in gene expression of lhx1-AS/AcRA caps versus AcRA
caps (Fig. 5). This statistical analysis resulted in a list of 81 probe
sets for further study (Fig. 5, S7).
While AcRA treated explants induce pronephric tissue at a high
frequency, the entire explant is not converted to kidney tissue and
markers for neural tissue, epithelium and muscle are also
expressed [49,50,51,52]. For this reason, we considered it
important to evaluate expression of our candidate genes using
whole-mount in situ hybridization. Of the 81 hits found on the
microarray (Fig. 5), we identified full-length cDNA or EST clones
for 66 genes (Fig. S7) and performed in situ hybridization on
embryos at stages 12.5, 15, 21 and 32. We identified a total of 17
genes with expression in the intermediate mesoderm at stage 15
(data not shown) and also later in the pronephric kidney at stage
32 (Fig. 6A, 6D, 6J, 6M and Fig. S8). Interestingly, we found
genes from all domains of the pronephric tubule, lending support
to the idea of Lhx1 being essential for the development of all
kidney derivatives of the somatic layer of the intermediate
mesoderm.
Figure 2. Inducible activation of Lhx1, defines a temporal
window of kidney field expansion. Embryos were injected (1xV2)
with 200 pg of LL-VP16-GR mRNA at the 8-cell stage. (A–L) In situ
hybridization for pax8 of embryos at stage 31, followed by MZ15 whole-
mount immunostaining. (A, C, E, G, I, K) Uninjected embryos. (B, D, F,
H, J, L) Injected embryos. Activation of LL-VP16-GR was controlled by
addition of dexamethasone (Dex) at specified stages. Dex was added to
uninjected and injected embryos at: (A, B) stage 10; (C, D) stage 12.5;
(E, F) stage 15; (G, H) stage 18; (I, J) stage 21; (K, L) stage 24. (M) Bar
graph with the percentage of injected embryos that showed expansion
after Dex treatment at different stages. Expansion of pax8 expression
was observed in 53% of the embryos for stage 10 (n = 36), 56% for stage
12.5 (n = 32), 84% for stage 15 (n = 32), 79% for stage 18 (n = 34), 40%
for stage 21 (n = 45) and 24% for stage 24 (n = 21).
doi:10.1371/journal.pone.0018858.g002
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To confirm that absence of lhx1 affects expression of the kidney
genes found in the microarray assay, we injected 300 pg of lhx1-AS
into 8-cell embryos (1xV2) and fixed them at stage 32 for in situ
hybridization. We randomly selected markers to cover all regions
of the pronephric kidney. The high stringency cutoff criteria and
statistical analysis narrowly eliminated hoxb7 from the final list.
Since expression of this gene has been well characterized in the
kidney of Xenopus and mice [53,54,55], we decided to include it
and analyze the effect of loss of lhx1 on the expression of this gene
in whole embryos. Injected embryos showed a reduced expression
of the proximal tubule markers, follistatin (Fig. 6A–C) and pax2
(Fig. 6D–F) (57%, 86% respectively). When markers of distal and
early distal tubule were analyzed in lhx1-AS-injected embryos,
expression of hoxb7 (Fig. 6G–I), laminin-b1 (Fig. 6J–L) and
neuropilin1 (Fig. 6M–O) was reduced in 92%, 94% and 90% of
embryos, respectively. Since we did not find any glomerular
markers among the 17 genes from the microarray, we decided to
test whether both layers of the intermediate mesoderm [56] are
affected by the absence of lhx1 expression. For this purpose, we
performed whole-mount in situ hybridization for wt1, a marker of
the splanchnic intermediate mesoderm [57]. As compared to
uninjected embryos (Fig. 6P, 6Q) and the control side (Fig. 6R,
6S), we observed reduced wt1 expression in 89% of the lhx1-AS
injected embryos (300 pg 1xV2) (Fig. 6T, 6U). These data suggest
Figure 3. Ectopic lhx1 expression causes a fate transformation event. Embryos were injected (1xV2) with 200 pg of LL-VP16 mRNA at the 8-
cell stage. Embryos were treated with hydroxyurea and aphidicolin (HUA) at stage 10.5/11. (A–D) In situ hybridization of embryos at stage 20 for pax8.
(A) Uninjected embryo. (B) Uninjected embryo treated with HUA. (C) Injected embryo. Expansion of pax8 expression was observed in 91% of the
embryos (n = 35). (D) Injected embryo treated with HUA. Expansion of pax8 expression was observed in 82% of the embryos (n = 33). (E–H) Whole-
mount immunostaining analysis of proliferation with anti-phospho-Histone H3 antibody, aPH3. (E) Uninjected embryo. (F) Uninjected embryo
treated with HUA. (G) Injected embryo. (H) Injected embryo treated with HUA. (I–L) In situ hybridization of embryos for the paraxial mesoderm
marker myoD. (I, J) Uninjected and injected embryos at stage 20. Reduced myoD expression was observed in 63% of the embryos (n = 51). (K, L)
Control and injected sides of the same embryo at stage 26. Reduced myoD expression was observed in 87% of the embryos (n = 30). Anterior somites
are highlighted with black brackets. (M–P) In situ hybridization of embryos for the lateral plate mesoderm marker scl. (M, N) Uninjected and injected
embryos at stage 20 (n = 45). Midline of the embryos is marked with a dotted line with anterior to the left. (O, P) Control and injected sides of the
same embryo at stage 26 (n = 43). The injected side of the embryos is marked with an asterisk.
doi:10.1371/journal.pone.0018858.g003
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that both intermediate mesoderm derivatives of the kidney are
affected by the absence of lhx1.
Discussion
By studying the progression of intermediate mesoderm to
pronephric kidney in Xenopus, we were able to readily gain access
to embryos prior to the onset of kidney development. This allowed
us to study the role of Lhx1 in specification of the nephric anlagen.
By manipulating lhx1 expression in Xenopus embryos we have
established that Lhx1 function is required during the specification
stage of pronephric kidney organogenesis. Expression of a
constitutively-active form of Lhx1 results in the expansion of the
kidney field and this ability is limited to the stages when
specification of kidney progenitor cells is occurring [37,52]. Our
observation that Lhx1 plays a role in driving the intermediate
mesoderm towards a renal progenitor cell population is in
agreement with two current published datasets: (1) lhx1 expression
has been shown to be directly regulated by RA signaling, and
potential RA responsive elements (RAREs) have been identified in
the lhx1 promoter [10]. Current dogma suggests that RA signaling
is the primary step in establishing the intermediate mesoderm, thus
putting lhx1 directly downstream of this initial pattering event
[10,13,58]. (2) lhx1 perduration maintains the expression of early
nephric markers and does not allow terminal differentiation of the
kidney field to proceed [36].
Studies have identified a signal transduction pathway that drives
specification of trunk mesoderm into distinct paraxial mesoderm
and intermediate mesoderm fates [59]. Our results reveal the
expansion of kidney field by over-expression of constitutively-
active Ldb1-Lhx1 is associated with a decrease in paraxial
mesoderm tissue. This result suggests that hyper-activation of
Lhx1 is able to recruit cells from the paraxial mesoderm to adopt a
nephric fate. These findings are in agreement with a report by
Carroll et al., which demonstrated ectopic kidney tissue induced by
co-injection of pax8 and lhx1 is always found within the paraxial
mesoderm or the intermediate mesoderm domains [25]. Tempo-
rally controlled activation of constitutively-active Ldb1-Lhx1
results in robust expansion of the kidney field at stages 15 and
18, during pronephric kidney specification. Notably, the kidney
specification stage is the period when many known renal inductive
factors are expressed [37]. Seeing as constitutively-active Ldb1-
Lhx1 shows maximal effect during this inductive period, but not
prior to this period, suggests that Lhx1 is possibly a competence
factor necessary for establishing a broad kidney field, thereby
making the field competent to respond to region specific renal
inductive signals [60]. This hypothesis is supported by a recent
report from Drews et al., which demonstrated that Lhx1 does not
have pronephric kidney inductive potential when over-expressed
in a Xenopus explant system, but can influence the expression of
multiple early nephrogenic factors [61].
Depletion of lhx1 within the nephric anlagen using DEED-AS
oligonucleotides resulted in a severe reduction or absence of the
kidney tubule. Chan et al., reported that injection of a dominant-
negative form of Lhx1 into the C2 and C3 blastomeres of 32-cell
embryos resulted in a disorganized and partial reduction of
proximal tubules but more distal regions are not affected. Based on
these results, they concluded that Lhx1 functions in proximal
tubule morphogenesis [30]. Even though the C2/C3 blastomeres
give rise to a portion of the kidney field, there is a substantial
contribution from the surrounding blastomeres [62]. By injecting
the V2 blastomere of 8-cell embryos, we targeted a larger segment
of lineages that will give rise to the kidney [40]. Therefore, our
observed reduction of marker gene expression from proximal
Figure 4. Depletion of lhx1 results in a loss of the pronephric kidney. Embryos were injected (1xV2) with 300 pg of ctrl-AS or lhx1-AS at the 8-
cell stage. (A, D, G, J) Uninjected embryos. (B, E, H, K) Embryos injected with ctrl-AS. (C, F, I, L) Embryos injected with lhx1-AS. (A–C) In situ
hybridization of embryos at stage 20 for the pronephric marker pax8. (C) Reduced or absent pax8 expression was observed in 47% and 53% of the
embryos, respectively (n = 34). (D–F) 3G8 whole-mount immunostaining was carried out at stage 32. (E) Reduced 3G8 staining was observed in 5% of
the embryos (n = 41). (F) Reduced 3G8 staining was observed in 76% of the embryos (n = 34). Insets show enlargement of 3G8 staining of the
proximal tubule. (G–I) 4A6 whole-mount immunostaining was carried out at stage 37/38. (H) Reduced 4A6 staining was observed in 9% of the
embryos (n = 23). (I) Reduced 4A6 staining was observed in 91% of the embryos (n = 34). (J–L) In situ hybridization of embryos at stage 39 for b1-NaK-
ATPase. (L) Reduced b1-NaK-ATPase expression was observed in 72% of the embryos (n = 29). (M) Bar graph with the percentage embryos injected
with the different doses of lhx1-AS that showed presence, reduction or absence of pax8 expression at stage 20. Lhx1-AS 100 pg: reduced pax8
expression was observed in 89%, absence in 4% and presence in 7% of the embryos (n = 28). Lhx1-AS 200 pg: reduced pax8 expression was observed
in 93% and presence in 7% of the embryos (n = 27). Lhx1-AS 300 pg: reduced of pax8 expression was observed in 47% and absent in 53% of the
embryos (n = 34). Lhx1-AS 400 pg: reduced pax8 expression was observed in 50% and absent in 50% of the embryos (n = 42). Lhx1-AS 300 pg+zflhx1
mRNA 25 pg: presence of pax8 expression was observed in 51% of the embryos (n = 41).
doi:10.1371/journal.pone.0018858.g004
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through distal tubule cells is likely due to targeting more of the
kidney field, demonstrating the importance of Lhx1 in specifica-
tion of the entire pronephric tubule.
In order to identify all domains of the kidney affected by the
absence of lhx1 expression, we subjected lhx1-depleted kidney
explants to microarray analysis. We found 81 probe sets that
showed significant reduction of expression in kidney explants.
Whole-mount in situ hybridization demonstrated that 17 of the
clones are expressed in the kidney. Importantly, expression pattern
analysis in whole embryos revealed that all segments of the
pronephric kidney derived from the somatic layer of the
intermediate mesoderm are altered when lhx1 is depleted.
Glomerular markers were not identified from the microarray
experiments. It is possible glomerular markers were eliminated
from our analysis due to a combination of low levels of expression
of podocyte markers in the explants and the stringent statistical
analysis of the microarray data. Additionally, a report by Carroll
et al., demonstrated that lhx1 expression was present in the
glomerular anlagen during specification stages, suggesting a
possible role in establishing the glomus [63]. We evaluated
expression of wt1 in embryos injected with lhx1-AS and found
expression of this gene to also be reduced. Therefore, Lhx1
function is essential for specification of both the somatic and
splanchnic intermediate mesoderm layers. Previously reported
microarray data analysis on mouse lhx1 mutant metanephric
mesenchyme, identified genes that are involved in patterning of
the nephric vesicle [64,65]. By using Xenopus as a model, we have
been able to study the process of specification of the intermediate
mesoderm, a stage of kidney development that is difficult to gain
access to in mice, and that was not analyzed by the previous
microarray studies. Taken together, our microarray analysis results
indicate that Lhx1 is involved in specification of the entire kidney
field. Further studies will be needed to identify additional factors
that drive the process of regional kidney tissue induction in an
Lhx1 competent kidney field.
Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol (0812734A-2) was approved by the Institutional Animal
Care and Use Committee of the University of Pittsburgh (Animal
Welfare Assurance Number: A3187-01).
Xenopus embryo manipulations and microinjections
Xenopus laevis embryos were obtained by artificial fertilization,
maintained in 0.26MMR and staged as previously described [5].
mRNA and/or lhx1-AS were co-injected with either fluorescein
dextran or rhodamine dextran. Synthesis of LL-CA, LL-VP16 and
zebrafish lhx1 mRNAs were made using the SP6 mMessage
mMachine kit (Ambion). For lhx1 over-expression studies, 200–
1200 pg of LL-CA or 50–300 pg of LL-VP16 were injected into
one of the V2 blastomeres (1xV2) at the 8-cell stage. Lhx1-AS and
ctrl-AS synthesis, sequence and specificity have been previously
described [22,45]. For lhx1-depletion experiments, 8-cell embryos
were injected (1xV2) with 100–400 pg of lhx1-AS or ctrl-AS. For
rescue experiments, 300 pg of lhx1-AS were coinjected with 25 pg
of zebrafish lhx1 mRNA into 8-cell embryos (1xV2). For
temporally-controlled activation of Lhx1, the glucocorticoid
receptor (GR) ligand-binding domain [66] was fused to the 39
end of the LL-VP16 construct (LL-VP16-GR). 8-cell stage
embryos were injected with 200 pg of LL-VP16-GR (1xV2).
Injected embryos were treated with 10mM of dexamethasone
(Dex) at indicated stages. For the cell proliferation studies, 200 pg
of LL-VP16 were injected into 8-cell embryos (1xV2), and these
embryos were subsequently treated with hydroxyurea and
aphidicolin (HUA) from stage 10.5 as previously described [44].
In situ hybridization and immunostaining
Whole-mount in situ hybridization was carried out as previously
described [67]. The pax8 construct, a gift from Tom Carroll, was
linearized with the restriction enzyme NotI and transcribed with T7
to generate an antisense probe. The myoD and scl constructs were
linearized with SalI and transcribed with T7 to generate antisense
probes. A b1-NaK-ATPase construct, gift from Oliver Wessely, was
linearized with EcoRI and transcribed with T7 for an antisense
probe. All other constructs used for probe synthesis were full-length
cDNA or EST image clones obtained from Open Biosystems
(http://openbiosystems.com/) and verified by sequencing. Whole-
mount in situ hybridizations were developed using BM Purple AP
Substrate (Roche). For whole-mount immunostaining, Xenopus
embryos were fixed in Dent’s (4:1 methanol:DMSO) for 4 hr at
RT. After fixation embryos were washed with 100% methanol
followed by rehydration. After incubation in blocking solution,
embryos were transferred to a solution with 3G8 and/or 4A6
monoclonal antibody [42] followed by incubation with anti-mouse
alkaline phosphatase IgG (Sigma) and developed using SIGMA-
FAST fast red tablets (Sigma). Monoclonal MZ15 and 12/101
antibodies were purchased from the Developmental Studies
Hybridoma Bank. For double labeling experiments, embryos were
fixed in MEMFA and processed for in situ hybridization followed by
immunostaining. Monoclonal anti-phospho-Histone H3 antibody
Figure 5. Microarray analysis of lhx1-depletion in organ
culture. Venn diagram outlining the distribution of probe sets in the
three organ culture treatments. Overlap between probe sets that
showed a 4-fold or greater increase in expression in AcRA treated
(AcRA) vs untreated (C) explants (pink), probe sets that presented a 2-
fold or greater decrease in expression on lhx1-AS/AcRA vs AcRA
explants (blue) and probe sets which expression showed less than a 0.5-
fold increase/decrease in injected (lhx1-AS) vs C explants were
considered unaffected (green).
doi:10.1371/journal.pone.0018858.g005
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was purchased from Abcam. For transverse sections, the in situ
hybridization processed embryos were embedded in low melting
point agarose (Sigma, A0701) and then sectioned at 50 mm using a
Vibratome (Leica VT1000 Series) [68].
Explants assay
2-cell Xenopus embryos were injected at the animal pole with
800 pg of lhx1-AS and allowed to develop until stage 8–9, at
which time the animal caps were dissected and cultured in 16
Danilchik’s solution with 161024 M RA and 10 ng/ml Activin
when required [51]. Explants were cultured until the appropriate
stage (described in the text) at which time they were assayed for
pronephric kidney induction by RT-PCR or processed for
microarray assays.
RNA extraction and RT-PCR
Total RNA was extracted followed by cDNA synthesis and PCR
as previously described [69]. The following PCR primers were
used: EF1aforward primer,59-CAGATTGGTGCTGGATATGC-
39; reverse primer, 59-CACTGCCTTGATGACTCCTA-39 [70],
Pax8 forward primer, 59-CCAACAGCAGCATCAGATC-39;
reverse primer, 59-CAATGACACCTGGCCGGATA-39
Microarray analysis
A total of 12 caps were pooled for each RNA preparation and the
analysis was performed in triplicate. Total RNA was extracted from
animal caps with the TRIzol (Invitrogen) isopropanol method, and
purified with the RNeasy Kit (Qiagen). The biotin-labeled cDNA
probe was generated using the Ovation Biotin system kit (NeuGen).
Figure 6. Absence of lhx1 affects all the domains of the pronephric kidney. Embryos were injected (1xV2) with 300 pg of lhx1-AS at the 8-
cell stage. (A–O) In situ hybridization of embryos at stage 32. (A–C) In situ hybridization for follistatin (fst). (A) Uninjected embryo. (B, C) Control and
injected sides of the same embryo are shown. (C) Reduced fst expression was observed in 57% of the embryos (n = 44). (D–F) In situ hybridization for
pax2. (D) Uninjected embryo. (E, F) Control and injected sides of the same embryo are shown. (F) Reduced pax2 expression was observed in 86% of
the embryos (n = 32). (G–I) In situ hybridization for hoxb7. (G) Uninjected embryo. (H, I) Control and injected sides of the same embryo are shown. (I)
Reduced hoxb7 expression was observed in 92% of the embryos (n = 38). (J–L) In situ hybridization for laminin-b1. (J) Uninjected embryo. (K, L)
Control and injected sides of the same embryo are shown. (L) Reduced laminin-b1 expression was observed in 94% of the embryos (n = 32). (M–O) In
situ hybridization for neuropilin1 (nrp1). (M) Uninjected embryo. (N, O) Control and injected sides of the same embryo are shown. (O) Reduced nrp1
expression was observed in 90% of the embryos (n = 40). (P–U) In situ hybridization of embryos at stage 24 for wt1. (P, Q) Uninjected embryo. (R–U)
Control and injected sides of the same embryo are shown. (T, U) Reduced wt1 expression was observed in 89% of the embryos (n = 37). (Q, S, U)
Transverse sections of embryos in P and R/T, respectively. Arrows indicate plane of section in appropriate panels.
doi:10.1371/journal.pone.0018858.g006
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Affymetrix GeneChip Xenopus laevis Genome Array (1st generation)
was used for this assay. Hybridization, staining, and scanning were
performed according to the instructions from Affymextrix. The
signals were quantified, and normalized by GCOS (Affymetrix).
Average signal value, t-test, and fold change were analyzed using
JMP Statistical Discovery Software, (http://www.jmp.com/).
Three replicates for each sample type were averaged, and probe
sets showing differences with a p value smaller than 0.05 and fold
value larger than 4-fold up or 2-fold down were considered as
‘change’ and selected for further study. The microarray data is
MIAME compliant and the raw data has been deposited in the
GEO database at NCBI (GSE24392).
Supporting Information
Figure S1 Lhx1 and pax8 expression in Xenopus embry-
os. Expression of lhx1 (A–E) and pax8 (F–J) was visualized by in situ
hybridization. The intermediate mesoderm (S12.5, S15) (A, B, F,
G) and subsequent kidney field (S19.5, S21, S32) (C–E, H–J) are
highlighted with black brackets.
(TIF)
Figure S2 Dose-dependent expansion of the kidney field
induced by LL-CA. Embryos were injected (1xV2) with different
doses of LL-CA mRNA at the 8-cell stage. (A–C, E, F, H, I, K,
L) In situ hybridization of embryos at stage 20 for the early
pronephric marker pax8. (D, G, J, M) Visualization of the injected
side (asterisk) by the presence of fluorescein dextran. (A)
Uninjected embryo. (B–D) Control and injected (200 pg) sides
of the same embryo are shown. (D) Expansion of pax8 expression
was observed in 39% of the embryos (n = 31). (E–G) Control and
injected (400 pg) sides of the same embryo are shown. (F)
Expansion of pax8 expression was observed in 42% of the embryos
(n = 33). (H–J) Control and injected (800 pg) sides of the same
embryo are shown. (I) Expansion of pax8 expression was observed
in 62% of the embryos (n = 34). (K–M) Control and injected
(1200 pg) sides of the same embryo are shown. (L) Expansion of
pax8 expression was observed in 82% of the embryos (n = 33). (N)
Bar graph with the percentage embryos injected with the different
doses of LL-CA that showed expansion of pax8 expression.
(TIF)
Figure S3 Dose-dependent expansion of the kidney field
induced by LL-VP16. Embryos were injected (1xV2) with
different doses of LL-VP16 mRNA at the 8-cell stage. (A–C, E, F,
H, I, K, L) In situ hybridization of embryos at stage 20 for the
early pronephric marker pax8. (D, G, J, M) Visualization of the
injected side (asterisk) by the presence of fluorescein dextran. (A)
Uninjected embryo. (B–D) Control and injected (50 pg) sides of
the same embryo are shown. (E–G) Control and injected (100 pg)
sides of the same embryo are shown. (H–J) Control and injected
(200 pg) sides of the same embryo are shown. (K–M) Control and
injected (300 pg) sides of the same embryo are shown. (L)
Expansion of pax8 expression was observed in 93% of the embryos
(n = 27). Arrow indicates the misshapen kidney field.
(TIF)
Figure S4 Analysis of secondary axis formation. Embryos
were injected (1xV2) with 200 pg of LL-VP16-GR mRNA at the 8-
cell stage. (A–L) In situ hybridization for pax8 of embryos at stage 31,
followed by 12/101 whole-mount immunostaining. (A, C, E, G, I,
K) Uninjected embryos. (B, D, F, H, J, L) Injected embryos.
Activation of LL-VP16-GR was controlled by addition of
dexamethasone (Dex) at specified stages. Dex was added to
uninjected and injected embryos at: (A, B) stage 10; (C, D) stage
12.5; (E, F) stage 15; (G, H) stage 18; (I, J) stage 21; (K, L) stage 24.
(TIF)
Figure S5 Dose-dependent reduction of the kidney field
induced by lhx1 depletion. Embryos were injected (1xV2)
with different doses of lhx1-AS at the 8-cell stage. (A–C, E, F,
H, I, K, L) In situ hybridization of embryos at stage 20 for the
early pronephric marker pax8. (D, G, J, M) Visualization of the
injected side (asterisk) by the presence of fluorescein dextran.
(A) Uninjected embryo. (B–D) Control and injected (100 pg)
sides of the same embryo are shown. (E–G) Control and
injected (200 pg) sides of the same embryo are shown. (H–J)
Control and injected (300 pg) sides of the same embryo are
shown. (I) Reduction of pax8 expression was observed in 47% of
the embryos and absence in 53% of the embryos (n = 34). (K–
M) Control and injected (400 pg) sides of the same embryo
areshown.
(TIF)
Figure S6 Depletion of lhx1 in explants for microarray
analysis. (A) RT-PCR analysis on lhx1-AS-injected animal caps
(AC) treated with Activin and retinoic acid (AcRA). Induction of
pax8 expression in animal caps at stage 15 by AcRA is inhibited by
injection of 800 pg of lhx1-AS. WE: whole embryos. RT-PCR
controls: -RNA, -RT and -cDNA. EF1a was used as loading
control. (B) Schematic of the procedure followed for the
microarray analysis of animal caps. 2-cell embryos were injected
in both blastomeres with a total of 800 pg of lhx1-AS. Embryos
injected with lhx1-AS and uninjected were cultured until blastula
stage (stage 8/9) when animal caps were dissected and cultured
until stage 13.5/14 in the presence or absence of AcRA in the
media. C: untreated animal caps.
(TIF)
Figure S7 Probe sets showing up-regulated expression
in the AcRA treated caps and down-regulated expression
in injected lhx1-AS/AcRA caps. Those genes in bold were
found to be expressed in the kidney. Fold increase, refers to the
relative increase in gene expression in AcRA vs untreated explants.
Fold decrease, refers to the relative decrease in gene expression in
lhx1-AS/AcRA vs AcRA explants. Abbreviation: WMIH, whole-
mount in situ hybridization.
(PDF)
Figure S8 Expression of kidney genes identified from
the microarray analysis.Whole-mount in situ hybridization of
stage 32 embryos was performed. Expression was found in
different domains of the pronephric kidney: proximal tubule (PT),
early distal tubule (EDT), distal tubule (DT), and connecting
tubule (CT). (A, B, H–L) Genes with expression in the PT. (C–L)
Genes with expression in the EDT. (E–L) Genes with expression in
the DT. (M) Gene with expression in the CT.
(TIF)
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